Posts in Oncology

ISMP leverages multidisciplinary expertise across hundreds of similar healthcare facilities to provide customized guidance on effective use of medication safety data.
The ISMP Medication Safety Self Assessment® for Oncology is designed to heighten awareness of distinguishing systems and practices related to the safe use of chemotherapy, biotherapy, and treatment-related drugs.
Last month the US Food and Drug Administration (FDA) granted accelerated approval to PRAXBIND (idarucizumab) for use in patients who take PRADAXA (dabigatran) and suffer a life-threatening bleeding event. Hospital pharmacies may stock Praxbind if dabigatran patients are treated in the hospital or...
Problem: ISMP has received three reports of accidental overdoses with fluorouracil in 2015—two within the past 6 weeks. Approved more than 50 years ago, fluorouracil was one of the first intravenous cancer drugs and is still a mainstay in combination curative or palliative therapy regimens treating...
Harness ISMP’s unparalleled experience and expertise to uncover root causes and hidden system failures and assist your organization in developing a comprehensive plan of action.
From one day high-alert safety check-ups to comprehensive enterprise risk assessments, ISMP helps uncover systemic areas that are vulnerable to medication error risk in your organization.